PFIZER, INC. |
Market Closed -
Other stock markets
|
After market 05:37:41 pm | |||
| 28.64 USD | -0.97% |
|
28.7 | +0.23% |
| 11:25pm | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| 10:00pm | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92
USD
Average target price
31.94
USD
Spread / Average Target
+10.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.52% | 164B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Sector Update: Health Care Stocks Gaining Late Afternoon